Combination cancer therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/555 (2006.01) A61K 31/337 (2006.01) A61K 31/40 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/655 (2006.01) A61K 31/70 (2006.01)

Patent

CA 2469615

The present invention relates to novel compositions comprising, (i) at least one of Taxol, Taxotere, bleomycin, carmustine, carboplatin, and doxorubicin; and (ii) MGd, a compound of Formula I. The present invention also relates to and methods of using said compositions to treat Cancer.

La présente invention porte sur de nouvelles compositions comprenant (i) au moins un des taxol, taxotère, bléomycine, carmustine, carboplatine et doxorubicine; et (ii) MGd, un composé de formule (I). L'invention porte également sur des procédés d'utilisation de ces compositions dans le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination cancer therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1871746

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.